INSIGHTS ON DRUG DEVELOPMENT
-
Facilitate Handling Of Bulk Powders With Dry Granulation
Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.
-
Get Smoother Separations, Faster: Troubleshoot Method Development
Strong chromatography requires more than separation. Fine-tuning pH, columns, and system volume prevents poor peak shape, while modeling tools streamline optimization for reproducible results.
-
Predicting Food Effects In Oral Drug Delivery Using PBPK Modeling
Learn how integrated PBPK and molecular dynamics modeling predicted an ~11% fed-state Cmax increase for fenofibrate, giving formulation teams earlier, mechanistic insight into food-dependent absorption.
-
From 51% Yield To 87% With Targeted Impurity Removal
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
-
Building A Science- And Risk-Based Bio-Decontamination Strategy10/5/2026
Annex 1 has made bio-decontamination central to sterility assurance, with isolator and barrier cycles now expected to be designed, justified, and reviewed across their lifecycle.
-
NGS In GMP Manufacturing: Reducing Risk, Increasing Return1/29/2026
Global regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
-
Accelerate Your pDNA And mRNA Process Development11/13/2025
Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
-
Nanomedicine Modalities Find Path To Clinic Through Analytics5/16/2025
Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.
-
Making Accelerated Predictive Stability Studies Even Faster With Software6/18/2026
Drug stability depends on environmental conditions, but testing every scenario experimentally isn’t practical. Accelerated predictive stability uses mathematical modeling to forecast degradation, helping scientists make faster, data-driven decisions early in development.
DRUG DEVELOPMENT SOLUTIONS
-
Explore this interactive PDF with information about technologies & end-to-end integrated CDMO services provided by Adare Pharma Solutions.
-
Review three of our key compounds — Testosterone Base, Testosterone Cypionate, and Testosterone Propionate — each presented with essential identifiers such as CAS numbers, structural features, and typical marketed dosage forms.
-
Support high-yield viral vector production with media designed for transfection efficiency, scalability, and reduced aggregation in HEK293 cells, ideal for AAV and LV workflows.
-
Curia’s expert scientists use advanced technology to produce and analyze high-quality recombinant proteins.
-
Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.